Using robots to take lung biopsies might be ‘transformative’ for most cancers sufferers

The alternative to treatment circumstances of lung most cancers could be “vastly improved” through the use of robots, specialists have stated.

Doctors on the Royal Brompton Hospital and St Bartholomew’s Hospital are utilizing a robotics-assisted bronchoscopy system as a part of a medical trial.

The Ion Endoluminal System (Ion) was developed by know-how firm Intuitive.

Its manoeuvrable robotic catheter is inserted into the affected person through their throat utilizing an endotracheal tube, permitting clinicians to entry hard-to-reach areas of the lung and take away biopsies with larger precision.

Kelvin Lau, marketing consultant thoracic surgeon for St Bartholomew’s Hospital, stated: “Current biopsy techniques carry risk and are not always accurate, and many patients end up waiting for a repeat scan. The uncertainty of the wait causes anxiety and could allow a cancer to grow and spread.

“With this shape-sensing robotic technology, I have the precision and stability to lock onto a very small lung nodule and obtain an accurate biopsy quickly and safely. This could transform early diagnosis and treatment, reduce the need for repeat scans and treat lung cancer earlier.”

In June, the Government introduced plans to roll-out a brand new lung most cancers screening programme in England.

Under the scheme, these aged 55 to 74 with a historical past of smoking will probably be provided screenings. It is hoped the transfer will detect lung most cancers earlier in 9,000 folks.

Mr Lau stated that whereas the UK “is leading the world” in lung most cancers screening, “only some of the lung nodules identified during screening are cancerous and need treatment”.

This new know-how is transformative for us as clinicians as a result of it permits us to entry and biopsy nodules of lower than 10mm in measurement in tough to achieve areas of the lungs. The likelihood of a treatment for these sufferers is subsequently vastly improved

Prof Pallav Shah

Professor Pallav Shah, marketing consultant respiratory doctor primarily based at Royal Brompton Hospital, stated the brand new know-how is “transformative” because it permits medical doctors to detect smaller cancerous lung nodules, growing a affected person’s survival price.

“When we see patients with cancerous lung nodules of more than 30mm, their five-year survival rate is around 68%, but if we are able to detect these nodules at a smaller size, when they are less than 10mm in size, we are looking at a 92% survival rate.

“This new technology is transformative for us as clinicians because it allows us to access and biopsy nodules of less than 10mm in size in difficult to reach areas of the lungs. The chance of a cure for these patients is therefore vastly improved.”

Prof Shah added: “The expanding national lung cancer screening programme in England will increase the number of suspicious nodules detected on CT scans at an earlier stage which will need to be biopsied to determine a diagnosis.

“We know that an earlier diagnosis of lung cancer leads to significantly improved outcomes for our patients.”

Dr Oliver Wagner, vice chairman and medical officer of endoluminal at Intuitive, stated: “Lung cancer represents a worldwide health crisis, characterised by distressing survival rates, even after surgical intervention. Within Europe, the UK has emerged as a pioneering force in transforming the clinical outcomes for individuals diagnosed with lung cancer.

“We are in full support of early nodule lung detection and diagnosis and our aim is to bring about a positive transformation in the care pathways for lung cancer, ultimately leading to improved prognosis and well-being of patients.”

The therapy panorama of lung most cancers has been remodeled over the past decade and it’s thrilling to see new diagnostic methods coming by the pipeline for this hard-to-treat illness

Marianne Baker, Cancer Research UK

Marianne Baker, analysis info supervisor at Cancer Research UK, stated developments in know-how for the therapy of lung most cancers are “exciting”.

“Lung cancer is the most common cause of cancer death in the UK with just 1 in 10 people surviving it for 10 years or more, and treatment options remain limited.

“The treatment landscape of lung cancer has been transformed over the last decade and it’s exciting to see new diagnostic strategies coming through the pipeline for this hard-to-treat disease.

“Ultimately, research like this can bring us closer to a world where more people live longer, better lives, free from the fear of cancer.”

Last month, the Royal College of Surgeons of England (RCS England) revealed a information on robotics-assisted surgical procedure, detailing how the know-how may make operations extra environment friendly and assist free-up NHS beds.

The doc outlined “significant advantages” of utilizing robots in surgical procedure, together with diminished post-op ache, fewer blood transfusions, extra environment friendly use of anaesthetics and shorter hospital stays for sufferers.

Leave a Comment